Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Details of the Company’s goodwill were as follows:



	December 31, 2015			December 31, 2014

	(in thousands)
Beginning balance	$	16,290		$	1,491
Additions from the acquisition of iSocket	—			11,778
Additions from the acquisition of Shiny	—			3,021
Additions from the acquisition of Chango	52,513			—
Error correction related to iSocket (See Note 7)	(2,317		)	—
Measurement period adjustment related to Chango (See Note 7)	(520		)	—
Other adjustment related to Chango (See Note 7)	(261		)	—
Ending balance	$	65,705		$	16,290

Details of the Company’s intangible assets were as follows:



	December 31, 2015			December 31, 2014

	(in thousands)
Amortizable intangible assets:
Developed technology	$	35,756		$	13,176
Customer relationships	25,330			3,330
Non-compete agreements	4,990			490
Trademarks	—			3
Total identifiable intangible assets, gross	66,076			16,999
Total accumulated amortization—intangible assets	(15,293		)	(2,909		)
Total identifiable intangible assets, net	$	50,783		$	14,090

Amortization expense of intangible assets for the years ended December 31, 2015, 2014, and 2013 were $15.7 million, $0.9 million, and $0.9 million, respectively.

As of December 31, 2015, the estimated remaining amortization expense associated with the Company’s intangible assets for each of the next five fiscal years was as follows:



Fiscal Year	Amount
	(in thousands)
2016	$	16,227
2017	13,725
2018	9,941
2019	8,680
2020 and thereafter	2,210
Total	$	50,783

No impairment of goodwill or intangible assets was identified for the years ended December 31, 2015, 2014, and 2013.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details